Radiopharmaceuticals to image infection and inflammation

Seminars in Nuclear Medicine

Volumn 31, Issue 4, 2001, Pages 286-295

  Boerman, Otto C ^a   Rennen, Huub ^a   Oyen, Wim J G ^a   Corstens, Frans H M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOTACTIC PEPTIDE; CIPROFLOXACIN TC 99M; DEFENSIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FLUORODEOXYGLUCOSE F 18; FORMYLMETHIONYLLEUCYLPHENYLALANINE; FORMYLMETHIONYLLEUCYLPHENYLALANINE TC 99M; GALLIUM CITRATE GA 67; GRANULOCYTE ANTIBODY; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; IMMUNOGLOBULIN G IN 111; IMMUNOGLOBULIN G TC 99M; INFECTON; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT I 123; INTERLEUKIN 2 TC 99M; INTERLEUKIN 8 TC 99M; LACTOFERRIN; LEUKOCYTE IN 111; LIPOSOME TC 99M; MONOCLONAL ANTIBODY; POLYPEPTIDE ANTIBIOTIC AGENT; RADIOPHARMACEUTICAL AGENT; RP 128; SELECTIN E ANTIBODY; SULESOMAB TC 99M; TECHNETIUM 99M; THROMBOCYTE FACTOR 4 TC 99M; TUFTSIN; TUFTSIN TC 99M; UBIQUICIDIN; UBIQUICIDIN 18 35; UBIQUICIDIN 29 41; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; CELL SUBPOPULATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DRUG ACTIVITY; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG RECEPTOR BINDING; DRUG SAFETY; GRANULOCYTOPENIA; HEADACHE; HUMAN; HYPOTENSION; INFECTION; INFLAMMATION; ISOTOPE LABELING; LEUKOCYTE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RADIODIAGNOSIS;

EID: 0034764267     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1053/snuc.2001.26189     Document Type: Article

References (93)

1. Gallium 67 citrate scanning in neoplastic and inflammatory lesions
2. Diagnostic evaluation of Ga-67 scanning of lung cancer and other diseases
3. Mechanism of gallium-67 accumulation in inflammatory lesions
4. 67Ga localization
5. The current role of gallium imaging in infection
6. Early gallium-67 abdominal imaging: Pitfalls due to bowel activity
7. The role of gallium-67 in the clinical evaluation of cancer
8. Detection of osteomyelitis at fracture nonunion sites: Comparison of two scintigraphic methods
9. Survey of radioactive agents for the in vitro labeling of phagocytic leucocytes. I. Soluble agents. II. Particles
10. Indium-111-labeled autologous leukocytes in man
11. Indium-111-labeled leukocytes for the localization of abscesses: Preparation, analysis, tissue distribution, and comparison with gallium-67 citrate in dogs
12. 99mTc-hexamethyl propylene-amineoxime for labeling leucocytes and imaging infection
13. 99mTc]HMPAO-leukocytes for imaging infection
14. Indium-111-labeled leukocytes for the detection of infection: Current status
15. Effect of chronicity of infection on the sensitivity of the In-111-labeled leukocyte scan
16. Failure of zidovudine prophylaxis after accidental exposure to HIV-1
17. The single late Tc-99m granulocyte antibody scan in inflammatory diseases
18. The in vivo binding behaviour of an I-123 labelled anti-granulocytes antibody (Granuloszint)
19. Rapid imaging of infections with a monoclonal antibody fragment (Leukoscan)
20. Rapid diagnostic imaging of acute, nonclassic appendicitis by leukoscintigraphy with sulesomab, a technetium-99m-labeled antigranulocyte antibody Fab' fragment
21. Use of Sulesomab, a radiolabeled antibody fragment, to detect osteomyelitis in diabetic patients with foot ulcers by leukoscintigraphy
22. Imaging inflammatory diseases with neutrophil-specific technetium-99m-labeled monoclonal antibody anti-SSEA-1
23. Neutrophil-specific 99mTc-labeled anti-CD15 monoclonal antibody imaging for diagnosis of equivocal appendicitis
24. Kinetic data of in vivo labelled granulocytes in humans with a murine Tc-99m-labelled monoclonal antibody
25. Effects of a 99mTc-labeled murine immunoglobulin M antibody to CD15 antigens on human granulocyte membranes in healthy volunteers
26. The use of monoclonal antibodies and antibody fragments in the imaging of infectious lesions
27. Radioimmunoconjugates in the detection of infection and inflammation
28. 99mTc]hexamethylpropyleneamine-oxime-labeled leukocyte scintigraphy in inflammatory bowel disease
29. Detection of soft-tissue infections and osteomyelitis using a technetium-99m-labelled antigranulocyte monoclonal antibody fragment
30. In vitro complex formation and biodistribution of mouse antitumor monoclonal antibody in cancer patients
31. Radiation dosimetry of a 99mTc-labeled IgM murine antibody to CD15 antigens on human granulocytes
32. Specific and nonspecific imaging of localized Fisher immunotype 1 Pseudomonas aeruginosa infection with radiolabeled monoclonal antibody
33. Locali-zation of Fc and Fab fragments of nonspecific polyclonal IgG at focal sites of inflammation
34. Effect of carbohydrate modification on the localization of human polyclonal IgG at focal sites of bacterial infection
35. Imaging infections with antibodies. A quantitative autoradiographic analysis
36. Indium-111-labeled human nonspecific immunoglobulin G: A new radiopharmaceutical for imaging infectious and inflammatory foci
37. Evaluation of infections of the locomotor system with indium-111-labeled human IgG scintigraphy
38. Indium-111-labeled human polyclonal immunoglobulin: Identifying focal infection in patients positive for human immunodeficiency virus (HIV)
39. 99mTc-HMPAO labelled leukocytes in inflammatory bowel disease
40. Technetium-99m labeled to human immunoglobulin G through the nicotinyl hydrazine derivative: A clinical study
41. Imaging vascular endothelial activation: An approach using radiolabeled monoclonal antibodies against the endothelial cell adhesion molecule E-selectin
42. 2 fragment of anti-E-selectin monoclonal antibody
43. Immunolocalization of active inflammatory bowel disease (IBD) using a monoclonal antibody against E-selectin
44. Use of a radiolabeled monoclonal antibody against E-selectin for imaging of endothelial activation in rheumatoid arthritis
45. 99mTc-labelled human non-specific immunoglobulin in radionuclide imaging of rheumatoid arthritis
46. 111In to image focal infection in rats
47. Detecting infection and inflammation with technetium-99m-labeled Stealth liposomes
48. Scintigraphic evaluation of experimental colitis in rabbits
49. Tc-99m-labeled liposomes to image experimental colitis in rabbits: Comparison with Tc-99m-HMPAO-granulocytes and Tc-99m-HYNIC-IgG
50. Scintigraphic evaluation of experimental chronic osteomyelitis
51. Tc-99m-PEG-liposomes for the scintigraphic detection of infection and inflammation: Clinical evaluation
52. Tc-99m-PEG-liposomes for the evaluation of colitis in Crohn's disease
53. Selective cell labeling: A potential radioactive agent for labeling of human neutrophils
54. Technique of leukocyte harvesting and labeling: Problems and perspectives
55. Imaging focal sites of bacterial infection in rats with indium-111-labeled chemotactic peptid analogs
56. Technetium-99m-labeled chemotactic peptides: Comparison with indium-111-labeled white blood cells for localizing acute bacterial infection in the rabbit
57. In vivo bioactivity and biodistribution of chemotactic peptide analogs in nonhuman primates
58. Imaging inflammation with Tc-99m labeled chemotactic peptides: Analogues with reduced neutropenia
59. A novel high affinity chemotactic peptide antagonist for infection imaging
60. The similarity between Tuftsin (Thr-Lys-Pro-Arg) receptors and Tuftsin antibody: A case of induced molecular mimicry
61. A new Tc-99m labeled peptide inflammation imaging agent
62. Evaluation of 99mTc-RP128 as a potential inflammation imaging agent: Human dosimetry and first clinical results
63. Specific targeting of infections foci with radioiodinated human recombinant interleukin-1 in an experimental model
64. Preferential localization of systemically administered radiolabeled interleukin-1a in experimental inflammation in mice by binding to the type II receptor
65. Imaging of infection in rabbits with radioiodinated interleukin-1 (α and β), its receptor antagonist and a chemotactic peptide: A comparative study
66. 123I-IL-ra in affected joints in patients with rheumatic arthritis
67. 123I-interleukin-2 labeling procedure and animal studies
68. The development of technetium-99m-labeled interleukin-2: A new radiopharmaceutical for the in vivo detection of mononuclear cell infiltrates in immune-mediated diseases
69. Interleukin-2 scintigraphy: An overview
70. Scintigraphy of acute inflammatory lesions in rats with radiolabeled recombinant human interleukin-8
71. Scintigraphy of osteomyelitis in man with human recombinant interleukin-8
72. Radiolabeled interleukin-8: Scintigraphic detection of infection within a few hours
73. Specific and rapid scintigraphic detection of infection with Tc-99m-labeled interleukin-8
74. Technetium-99m-white blood cell-specific imaging agent developed from platelet factor 4 to detect infection
75. Tc-99m P483H for imaging infection: Phase 2 multicenter trial results
76. 99mTc infection imaging with radiolabeled white-cell imaging in the evaluation of bacterial infection
77. Evaluation of the efficacy of 99mTc-infection, a novel agent detecting sites of infection
78. Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by in-creased leukocyte accumulation
79. 99mTc-labeled human neutrophil peptide-1
80. Technetium-99m labeled antimicrobial peptides discriminate between bacterial infections and sterile inflammations
81. PET in oncology. I. Lung, breast, soft tissue sarcoma
82. PET in oncology. II. Other tumours
83. Fluorine-18 deoxyglucose and false-positive results: A major problem in the diagnostics of oncological patients
84. High [18F]-fluorodeoxyglucose uptake in abdominal abscesses: A PET study
85. FDG-PET in infectious lesions: The detection and assessment of lesion activity
86. PET scanning and the human immunodeficiency virus-positive patient
87. Chronic osteomyelitis: Detection with FDG PET and correlation with histopathologic findings
88. Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: Preliminary results
89. Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis
90. Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging
91. Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: Results of histologically confirmed cases
92. Infection imaging using whole-body FDG-PET
93. 18F-FDG PET in detecting infected lower limb prosthesis implants